2013
Dosimetric and clinical predictors of the development of moist desquamation in breast cancer irradiation
Rutter C, Qin L, Higgins S, Moran M, Evans S. Dosimetric and clinical predictors of the development of moist desquamation in breast cancer irradiation. Journal Of Radiation Oncology 2013, 3: 147-152. DOI: 10.1007/s13566-013-0129-0.Peer-Reviewed Original ResearchMoist desquamationWhole breast radiotherapyAdjuvant whole breast radiotherapyLogistic regressionResultsTwenty-three patientsBreast cancer irradiationKaplan-Meier analysisImpact of patientLog-rank testMultivariate logistic regressionSignificant predictorsDose-volume relationshipClinical predictorsConsecutive patientsPatient factorsBreast radiotherapyGy fractionsCancer irradiationPatientsRadiotherapyBMIBreastTreatment factorsGyDesquamation
2009
Local Therapy in BRCA1/2 Carriers with Operable Breast Cancer: Comparison of Breast Conservation and Mastectomy.
Pierce L, Phillips K, Griffith K, Buys S, Gaffney D, Moran M, Haffty B, Ben-David M, Garber J, Merajver S, Balmanya J, Meirovitz A, Domchek S. Local Therapy in BRCA1/2 Carriers with Operable Breast Cancer: Comparison of Breast Conservation and Mastectomy. Cancer Research 2009, 69: 959-959. DOI: 10.1158/0008-5472.sabcs-09-959.Peer-Reviewed Original ResearchContralateral breast cancerOperable breast cancerBreast conservationBreast cancerLocal therapyBRCA1/2 mutationsDistant failureClinical characteristicsBRCA1/2 carriersLocal failureBC-specific survivalDeleterious BRCA1/2 mutationsLocal treatment optionsInvasive lobular cancerGermline BRCA1/2 mutationsSignificant predictorsSignificant differencesOnly significant predictorAdjuvant chemotherapyBCT patientsOverall survivalContralateral breastLobular cancerLocal recurrenceRandomized trials